Mifepristone 150mg or 200mg combined with prostaglandin is a safe, effective and acceptable drug for early pregnant women.
The use of mifepristone has great limitations. When mifepristone is used in medical abortion, the indications, contraindications and corresponding precautions must be strictly controlled. The combination of mifepristone and prostaglandin is suitable for terminating the pregnancy of early pregnant women under 35 years old within 49 days after menopause. However, medical abortion cannot be used in the following situations: those who are allergic to mifepristone; Patients with heart, liver and kidney diseases and patients with adrenal insufficiency; The use of prostaglandin drugs has contraindications, such as glaucoma, asthma and allergy to prostaglandin drugs; Pregnancy with intrauterine device and suspected ectopic pregnancy; Tumor patients related to steroid hormones; Acute stage of some diseases, inflammatory stage of reproductive organs and sexually transmitted diseases such as gonorrhea.
In the process of treatment and follow-up, if there is a lot of bleeding or other abnormal conditions, you should seek medical advice in time. After medication, a small amount of vaginal bleeding usually occurs earlier, and some parturients have a longer postpartum bleeding time. A few early pregnant women can have spontaneous abortion after taking medicine. About 80% of pregnant women excrete chorioallantoic within 6 hours after taking prostaglandin drugs, and about 10% of pregnant women excrete pregnancy within one week after taking prostaglandin drugs. After 8- 15, you should go to the original treatment hospital for a follow-up visit to determine the effect of abortion. B-ultrasound examination or blood HCG determination should be done when necessary. If it is diagnosed as incomplete abortion or continued pregnancy, it should be handled in time. The use of mifepristone to terminate early pregnancy failed and must be terminated by induced abortion.
Reference /view/ 1490845.htm? fr=ala0_ 1